Stock listing
NTLA Stock Price, News, Filings & Events — Intellia Therapeutics, Inc.
Selected listing: NTLA · NASDAQ · USD · US
This page tracks Intellia Therapeutics, Inc.'s NTLA:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following NTLA:NASDAQ. NTLA:NASDAQ is the stock-level entry point for investors researching Intellia Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Intellia Therapeutics, Inc. is a public biotechnology company based in the United States, focused on developing innovative gene editing therapies. The company operates under the ticker NTLA and has a market capitalization of approximately $1.5 billion. Intellia is dedicated to advancing its research and development efforts in the field of genetic medicine.
- Ticker
- NTLA:NASDAQ
- Asset type
- Stock
- Market cap
- $1.65B
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
Intellia Therapeutics, Inc. NTLA:NASDAQ stock context
This page tracks Intellia Therapeutics, Inc.'s NTLA:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following NTLA:NASDAQ. NTLA:NASDAQ is the stock-level entry point for investors researching Intellia Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Intellia Therapeutics, Inc. is a public biotechnology company based in the United States, focused on developing innovative gene editing therapies. The company operates under the ticker NTLA and has a market capitalization of approximately $1.5 billion. Intellia is dedicated to advancing its research and development efforts in the field of genetic medicine.
Latest news from Intellia Therapeutics, Inc.
Intellia Therapeutics Announces FDA Acceptance of Biologics License Application with Priority Review for Lonvoguran Ziclumeran (Lonvo-z) for Hereditary Angioedema (HAE)
September 8, 2026
Intellia Therapeutics Secures Non-Dilutive Debt Facility with OrbiMed for up to $400 Million
September 4, 2026
Intellia Therapeutics to Present at Morgan Stanley 24th Annual Global Healthcare Conference
September 4, 2026
Intellia Therapeutics to Hold Conference Call on August 6 to Discuss Second Quarter 2026 Financial Results and Business Updates
July 30, 2026
Intellia Therapeutics Reports Additional Positive Phase 3 Results for Lonvoguran Ziclumeran (lonvo-z) in Patients with Hereditary Angioedema
June 13, 2026
Intellia Therapeutics, Inc. earnings calls
Intellia Therapeutics, Inc. (NTLA) Q2 2026 Earnings Call
August 6, 2026 · Replay with transcript and chapters
Intellia Therapeutics, Inc. (NTLA) Q4 2025 Earnings Call
February 26, 2026 · Replay with transcript and chapters
Intellia Therapeutics, Inc. (NTLA) Q3 2025 Earnings Call
November 6, 2025 · Replay with transcript and chapters
Intellia Therapeutics, Inc. (NTLA) Q2 2025 Earnings Call
August 7, 2025 · Replay with transcript and chapters
Intellia Therapeutics, Inc. (NTLA) Q1 2025 Earnings Call
May 8, 2025 · Replay with transcript and chapters
Intellia Therapeutics, Inc. (NTLA) Q4 2024 Earnings Call
February 27, 2025 · Replay with transcript and chapters
Research Intellia Therapeutics, Inc.
Intellia Therapeutics, Inc. investor report
Review AI stock analysis and investor report context for NTLA:NASDAQ.
Intellia Therapeutics, Inc. company profile
View the public company page for Intellia Therapeutics, Inc. on 6ix.
Intellia Therapeutics, Inc. news
Read company news and market updates connected to Intellia Therapeutics, Inc..
Intellia Therapeutics, Inc. investor events
Find investor webinars, events, and replay context for Intellia Therapeutics, Inc..
Alternate listings
38I:GETTEX
DE · EUR
Alternate listing for Intellia Therapeutics, Inc.; the primary context on this page is NTLA:NASDAQ.
A2AG6H:LSX
DE · EUR
Alternate listing for Intellia Therapeutics, Inc.; the primary context on this page is NTLA:NASDAQ.
NTLA:BOATS
US · USD
Alternate listing for Intellia Therapeutics, Inc.; the primary context on this page is NTLA:NASDAQ.
38I:TRADEGATE
DE · EUR
Alternate listing for Intellia Therapeutics, Inc.; the primary context on this page is NTLA:NASDAQ.
A2AG6H:LS
DE · EUR
Alternate listing for Intellia Therapeutics, Inc.; the primary context on this page is NTLA:NASDAQ.
38I:HAM
DE · EUR
Alternate listing for Intellia Therapeutics, Inc.; the primary context on this page is NTLA:NASDAQ.
0JBU:LSE
GB · USD
Alternate listing for Intellia Therapeutics, Inc.; the primary context on this page is NTLA:NASDAQ.
38I:FWB
DE · EUR
Alternate listing for Intellia Therapeutics, Inc.; the primary context on this page is NTLA:NASDAQ.
38I:SWB
DE · EUR
Alternate listing for Intellia Therapeutics, Inc.; the primary context on this page is NTLA:NASDAQ.
38I:BX
CH · CHF
Alternate listing for Intellia Therapeutics, Inc.; the primary context on this page is NTLA:NASDAQ.
38I:DUS
DE · EUR
Alternate listing for Intellia Therapeutics, Inc.; the primary context on this page is NTLA:NASDAQ.
38I:MUN
DE · EUR
Alternate listing for Intellia Therapeutics, Inc.; the primary context on this page is NTLA:NASDAQ.